Approval · Notice of Compliance 2077 · 1999
TIMOHEXAL: Notice of Compliance 2077
Issued May 28, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2077
- Date
- May 28, 1999
- Company
- Hexal Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Elevated intraocular pressure therapy
- Canadian reference product
- TIMOPTIC (Merck Frosst)
Products in this notice
Medicinal ingredients
- TIMOLOL MALEATE 0.25 PER
- TIMOLOL MALEATE 0.5 PER